We are live on ! Find out more
PGP

Prescott General Partners Portfolio holdings

AUM $1.37B
1-Year Est. Return 23.81%
This Fund
S&P 500
This Quarter Est. Return
-10.59%
1 Year Est. Return
+23.81%
3 Year Est. Return
+67.15%
5 Year Est. Return
+9.62%
10 Year Est. Return
+525.75%
AUM
$1.27B
AUM Growth
-$183M
Cap. Flow
-$1.37M
Cap. Flow %
-0.11%
Top 10 Hldgs %
100%
Holding
12
New
Increased
Reduced
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SANA icon
Sana Biotechnology
SANA
+$785K
2
ALT icon
Altimmune
ALT
+$585K

Sector Composition

Rank Sector Weight
1 Financials 71.64%
2 Industrials 10.21%
3 Consumer Discretionary 9.77%
4 Communication Services 7.75%
5 Healthcare 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CACC icon
1
Credit Acceptance
CACC
$5.93B
$715M 56.15%
1,632,368
WRLD icon
2
World Acceptance Corp
WRLD
$837M
$197M 15.49%
2,037,495
W icon
3
Wayfair
W
$11.5B
$124M 9.77%
3,823,239
YELP icon
4
Yelp
YELP
$1.45B
$98.7M 7.75%
2,909,751
CMPR icon
5
Cimpress
CMPR
$2.38B
$95.6M 7.51%
3,906,492
GIC icon
6
Global Industrial
GIC
$1.36B
$34.3M 2.7%
1,279,677
VAPO
7
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$4.01M 0.32%
319,655
LCTX icon
8
Lineage Cell Therapeutics
LCTX
$272M
$2.09M 0.16%
1,851,851
HUMA icon
9
Humacyte
HUMA
$177M
$1.85M 0.15%
568,246
SER icon
10
Serina Therapeutics
SER
$30.6M
$104K 0.01%
5,265
ALT icon
11
Altimmune
ALT
$543M
-50,000
Closed -$585K
SANA icon
12
Sana Biotechnology
SANA
$865M
-122,097
Closed -$785K

Similar funds

Prescott General Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Prescott General Partners held 12 positions worth $1.27B, down 13% from $1.46B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Prescott General Partners's Q3 2022 filing shows 2 closed positions. The largest sale was Sana Biotechnology, an estimated $785K.

By sector, the portfolio is most concentrated in Financials at 72% of assets, up from 69% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Prescott General Partners fully exited Sana Biotechnology in Q3 2022, selling an estimated $785K.
  • Prescott General Partners's ten largest holdings make up 100% of its $1.27B portfolio in Q3 2022.
  • Prescott General Partners opened 0 new positions and closed 2 in Q3 2022.
  • Prescott General Partners's portfolio value fell 13% quarter-over-quarter to $1.27B.

Based on Prescott General Partners's 13F filing for Q3 2022, filed 14 Nov 2022.